21 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterExpression profiling by high throughput sequencing Remove filterTXT Remove filterKornelia Polyak
GSE24491
Gene expression profiling of human tissue samples using SAGE-Seq
  • Expression profiling by high throughput sequencing
14 Kornelia Polyak Oct 05, 2010
GSE25291
Altered antisense-to-sense transcript ratios in breast cancer: Sage-Seq
  • Expression profiling by high throughput sequencing
21 Kornelia Polyak Dec 10, 2010
GSE25292
Altered antisense-to-sense transcript ratios in breast cancer
28 Kornelia Polyak Dec 10, 2010
GSE26140
Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium [SAGE-Seq]
  • Expression profiling by high throughput sequencing
15 Kornelia Polyak Mar 01, 2011
GSE26141
Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium
41
  • Download icon TXT
Kornelia Polyak Mar 01, 2011
GSE22917
SAGE-Seq gene expression profiles of Hs578T, MCF7, and SUM159PT cells treated with STAT3 or non-targeting siRNAs, DMSO, or CXCR2, PTGIS, HAS1, PFKFB3, JAK, or NQO1 inhibitor
  • Expression profiling by high throughput sequencing
27 Kornelia Polyak Sep 08, 2011
GSE32017
Molecular profiling of human mammary gland links breast cancer risk to a p27+ cell population with progenitor characteristics
42 Kornelia Polyak Jun 13, 2013
GSE45732
Gene expression analysis of breast cancer cell-lines
  • Expression profiling by high throughput sequencing
14 Kornelia Polyak Jun 17, 2014
GSE46073
Gene expression and genome-wide location analysis of breast cancer cell-lines
41 Kornelia Polyak Jun 17, 2014
GSE38548
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer
106 Kornelia Polyak Jun 09, 2015
GSE38790
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [DGE]
  • Expression profiling by high throughput sequencing
10 Kornelia Polyak Jun 10, 2015
GSE63582
Response and resistance to BET bromodomain inhibitors in triple negative breast cancer [RNA-Seq]
  • Expression profiling by high throughput sequencing
28 Kornelia Polyak Jan 07, 2016
GSE104985
KDM5B links cellular transcriptome heterogeneity to therapy resistance (RNA-Seq)
  • Expression profiling by high throughput sequencing
118 Kornelia Polyak Oct 03, 2018
GSE104988
KDM5B links cellular transcriptome heterogeneity to therapy resistance
333 Kornelia Polyak Oct 03, 2018
GSE109281
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments
  • Expression profiling by high throughput sequencing
121 Kornelia Polyak Sep 24, 2019
GSE131099
Synthetic lethal and resistance interactions with BET bromodomain inhibitors [RNA-Seq]
  • Expression profiling by high throughput sequencing
62 Kornelia Polyak Mar 30, 2020
GSE131102
Synthetic lethal and resistance interactions with BET bromodomain inhibitors
210 Kornelia Polyak Mar 30, 2020
GSE131984
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer [scRNA-Seq]
  • Expression profiling by high throughput sequencing
8 Kornelia Polyak Apr 08, 2020
GSE161420
Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (bulkRNA-Seq and Exome-Seq)
60 Kornelia Polyak Apr 21, 2021
GSE161423
Divergent resistance mechanisms to HER2-targeted therapies in breast cancer
64 Kornelia Polyak Apr 21, 2021